PMID: 15228154Jul 2, 2004Paper

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition

Therapeutic Drug Monitoring
Rafael de la TorreJordi Camí

Abstract

MDMA (3,4-methylenedioxymethamphetamine, ecstasy) is a widely misused psychostimulant drug abused among large segments of the young population. Pharmacologically it displays effects related to amphetamine-type drugs and a set of distinctive effects (closeness to others, facilitation to interpersonal relationship, and empathy) that have been named by some authors "entactogen" properties. MDMA is a potent releaser and/or reuptake inhibitor of presynaptic serotonin (5-HT), dopamine (DA), and norepinephrine (NE). These actions result from the interaction of MDMA with the membrane transporters involved in neurotransmitter reuptake and vesicular storage systems. The most frequent effects after MDMA/ecstasy administration are euphoria, well-being, happiness, stimulation, increased energy, extroversion, feeling close to others, increased empathy, increased sociability, enhanced mood, mild perceptual disturbances, changed perception of colors and sounds, somatic symptoms related to its cardiovascular and autonomic effects (blood pressure and heart rate increase, mydriasis), and moderate derealization but not hallucinations. Acute toxic effects are related to its pharmacologic actions. The serotonin syndrome (increased muscle rigidity, h...Continue Reading

References

Jan 1, 1987·Journal of Toxicology. Clinical Toxicology·M J SmilksteinB H Rumack
Jan 1, 1996·European Journal of Clinical Pharmacology·U JeppesenK Brøsen
Nov 1, 1996·Journal of Analytical Toxicology·G W KunsmanM L Smith
Jun 1, 1997·Biochemical Pharmacology·D WuE M Sellers
Jun 23, 1998·Lancet·J A HenryM Forsling
Dec 16, 1998·Lancet·J A Henry, I R Hill
Feb 24, 1999·Lancet·R de la TorreJ Segura
Feb 15, 2000·British Journal of Clinical Pharmacology·R de la TorreJ Camí
Nov 1, 2000·JAMA : the Journal of the American Medical Association·M BaggottJ Zehnder
Nov 21, 2000·Annals of the New York Academy of Sciences·R PacificiR de la Torre
Nov 21, 2000·Annals of the New York Academy of Sciences· de la Torre RJ Cami
Dec 26, 2001·The Journal of Pharmacology and Experimental Therapeutics·Cándido Hernández-LópezRafael de La Torre
Jan 5, 2002·Advances in Experimental Medicine and Biology·T J MonksS S Lau
Feb 20, 2002·British Journal of Clinical Pharmacology·Leif BertilssonAyman Al-Shurbaji
Jul 4, 2002·QJM : Monthly Journal of the Association of Physicians·T K HartungJ A Henry
Sep 24, 2002·The Annals of Pharmacotherapy·Tony Antoniou, Alice Lin-In Tseng
Oct 31, 2002·Human Psychopharmacology·Matthias E. Liechti, Franz X. Vollenweider
Feb 14, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Kirk M BertelsenDavid J Greenblatt
Feb 27, 2003·Addiction·Erkki VuoriMatti Jäntti
Apr 2, 2003·Pharmacology & Therapeutics·J C Cole, H R Sumnall
Jul 19, 2003·Pharmacological Reviews·A Richard GreenM Isabel Colado
Aug 12, 2003·Journal of Analytical Toxicology·Simona PichiniRafael de la Torre
Dec 3, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Mitona PujadasRafael de la Torre

❮ Previous
Next ❯

Citations

Jan 11, 2005·Neurotoxicity Research·H G Baumgarten, L Lachenmayer
Mar 7, 2012·Archives of Toxicology·Márcia CarvalhoMaria de Lourdes Bastos
Jan 14, 2009·Psychopharmacology·A Richard GreenKevin C F Fone
May 1, 2007·Analytical and Bioanalytical Chemistry·Thomas Kraemer, Liane D Paul
Feb 3, 2009·Analytical and Bioanalytical Chemistry·Melanie MuellerHans H Maurer
Jul 26, 2005·European Journal of Clinical Pharmacology·Rafael de la TorreJordi Camí
Jan 16, 2007·European Journal of Nuclear Medicine and Molecular Imaging·M L Soto-MontenegroM Desco
Jul 3, 2008·International Journal of Legal Medicine·Daniela CerretaniVittorio Fineschi
Apr 1, 2009·Cardiovascular Toxicology·Sylvia K ShenoudaPamela A Lucchesi
Oct 12, 2013·Life Sciences·Anita H LewinP Anantha Reddy
Dec 19, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Johannes G RamaekersElia Formisano
Dec 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael H BaumannNicholas V Cozzi
Jul 7, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Annis MechanGeorge A Ricaurte
Sep 30, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rodney J IrvineJason M White
Jul 5, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Brian J PiperJerrold S Meyer
Jan 4, 2008·ILAR Journal·Michael A Nader, Paul W Czoty
Oct 19, 2006·Pharmacogenetics and Genomics·Helena CarmoJan G Hengstler
Mar 12, 2008·Behavioural Pharmacology·Matthew R SkeltonCharles V Vorhees
Apr 28, 2011·Behavioural Pharmacology·Adam StewartAllan V Kalueff
Jul 16, 2008·Journal of Clinical Psychopharmacology·Erin A KolbrichMarilyn A Huestis
Sep 17, 2008·Journal of Clinical Psychopharmacology·Brian O'MathúnaRafael de la Torre
Apr 8, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ximena PerfettiRafael de la Torre
Aug 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael H BaumannMarilyn A Huestis
Oct 22, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Marta ConcheiroMarilyn A Huestis
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Bardia JamaliFarzad Kobarfard
Jan 27, 2009·Clinical Chemistry·Allan J BarnesMarilyn A Huestis
Jul 29, 2005·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Zivorad MalicevićMarina Jovanović
Jun 4, 2014·PloS One·José Martínez-ClementeJorge Camarasa
Jun 19, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Emily J RossGregg D Stanwood
Mar 26, 2014·Nature Reviews. Nephrology·Randy L Luciano, Mark A Perazella
Mar 5, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Joseph M HerndonTerrence J Monks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.